Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

219
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
219
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

172
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
172
Pneumonia IV: Management01:28

Pneumonia IV: Management

455
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
455
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

452
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
452
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

594
The pathophysiology of pneumonia involves the following steps:
594
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

342
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
342

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bi-allelic variants in NRDC cause a neurodevelopmental disorder characterized by neonatal lethality, microcephaly, and brain abnormalities.

American journal of human genetics·2026
Same author

Management of large anterior mediastinal mass by video-assisted thoracoscopic surgery.

Journal of cardiothoracic surgery·2026
Same author

Novel Genetic Findings in Stuve-Wiedemann Syndrome: A Case Report and Review of Literature.

Clinical case reports·2026
Same author

Urinary bladder collision tumors: A case report and literature review.

Medicine international·2025
Same author

Outbreak of Meningitis in Iraq in 2023.

Global pediatric health·2024
Same author

Epigenomic and phenotypic characterization of DEGCAGS syndrome.

European journal of human genetics : EJHG·2024

Related Experiment Video

Updated: Sep 17, 2025

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
06:06

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

1.8K

Vancomycin Resistance Streptococcus pneumoniae, a Case Report.

Zana Baqi Najmadden1, Khalid Hama Salih2, Jihad Ibrahim Hama1

  • 1University of Halabja, Halabja, Kurdistan Region, Iraq.

Sage Open Pediatrics
|July 4, 2025
PubMed
Summary

A rare case of vancomycin-resistant Streptococcus pneumoniae was identified in a 9-month-old infant in Iraq. This finding highlights the urgent global threat of antibiotic resistance and the need for new treatment strategies.

Keywords:
Streptococcus pneumoniaeantibiotic resistancemeningitisvancomycin

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.2K
Biochemical and Structural Characterization of the Carbohydrate Transport Substrate-binding-protein SP0092
08:53

Biochemical and Structural Characterization of the Carbohydrate Transport Substrate-binding-protein SP0092

Published on: October 2, 2017

30.4K

Related Experiment Videos

Last Updated: Sep 17, 2025

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
06:06

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

1.8K
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.2K
Biochemical and Structural Characterization of the Carbohydrate Transport Substrate-binding-protein SP0092
08:53

Biochemical and Structural Characterization of the Carbohydrate Transport Substrate-binding-protein SP0092

Published on: October 2, 2017

30.4K

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Clinical Medicine

Background:

  • Streptococcus pneumoniae causes invasive pneumococcal disease, particularly in children.
  • Antibiotics are crucial for treating bacterial infections, but antibiotic resistance is a growing global health crisis.
  • Vancomycin resistance in S. pneumoniae has not been previously reported in Iraq.

Observation:

  • A 9-month-old infant presented with symptoms including fever, irritability, and decreased oral intake.
  • Cerebrospinal fluid analysis revealed signs of bacterial meningitis: turbid appearance, pleocytosis, high protein, and low sugar.
  • Culture and sensitivity tests identified Streptococcus pneumoniae.

Findings:

  • The isolated Streptococcus pneumoniae strain exhibited resistance to vancomycin.
  • This marks the first reported case of vancomycin resistance in S. pneumoniae in Iraq.

Implications:

  • This case underscores the escalating challenge of antimicrobial resistance worldwide.
  • The emergence of vancomycin resistance in S. pneumoniae necessitates urgent development of alternative therapeutic approaches.
  • Effective strategies are crucial to combat the potential post-antibiotic era where infections become untreatable.